Capital Asset Advisory Services’s Zimmer Biomet ZBH Stock Holding History

Capital Asset Advisory Services’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,038	Closed	-$215K	–	333
2023 Q3	$215K	Sell	2,038 -379	-16%	-$48.1K	0.01%	294
2023 Q2	$344K	Sell	2,417 -218	-8%	-$29.6K	0.02%	238
2023 Q1	$340K	Sell	2,635 -441	-14%	-$55.4K	0.03%	237
2022 Q4	$392K	Sell	3,076 -194	-6%	-$22.5K	0.03%	236
2022 Q3	$342K	Sell	3,270 -346	-10%	-$38K	0.04%	227
2022 Q2	$381K	Buy	3,616 +1,154	+47%	+$137K	0.04%	269
2022 Q1	$315K	Buy	+2,462	New	+$297K	0.03%	319
2021 Q1	–	Sell	-1,090	Closed	-$163K	–	1532
2020 Q4	$163K	Buy	+1,090	New	+$154K	0.03%	373

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Asset Advisory Services's ZBH Position: Q4 2023 in Review

Capital Asset Advisory Services sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 2,038 shares — an estimated $215K sold.

Capital Asset Advisory Services first reported a position in ZBH in Q4 2020 and held it in 8 quarters. The position peaked at $392K in Q4 2022. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

Capital Asset Advisory Services reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
Capital Asset Advisory Services sold 2,038 Zimmer Biomet shares in Q4 2023, an estimated $215K.
Capital Asset Advisory Services first reported a position in Zimmer Biomet in Q4 2020 and held it in 8 quarters.
Capital Asset Advisory Services's Zimmer Biomet position peaked at $392K in Q4 2022.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Capital Asset Advisory Services's 13F filing for Q4 2023, filed 9 Jan 2024.